What is the primary outcome of the ARISTOTLE trial?
The primary outcome of the ARISTOTLE trial was to compare the effectiveness of apixaban versus warfarin in patients with atrial fibrillation in terms of stroke and systemic embolism, major bleeding, and death from any cause.